ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990